Position OverviewVerve Therapeutics - a wholly owned subsidiary of Eli Lilly and Company - is seeking a Senior Director, Global New Product Planning (NPP) to shape the clinical development and commercial strategy for our cardiovascular gene editing portfolio. NPP is the bridge between our research organization and customers, and in this role, you will work to deliver meaningful experiences for patients while meeting the needs of physicians and payers.
This position requires an "out-of-the-box" thinker who can challenge existing healthcare norms and treatment paradigms. The questions in front of you have not been answered before in a prevalent, chronic disease: What does a target product profile look like for a single-course medicine? What level of evidence will build trust with patients, doctors, regulators, and payers? How should a one-time therapy be valued against lifelong daily treatment? Is it possible to shape a treatment paradigm oriented around early prevention, rather than delayed intervention?
This high-visibility position collaborates across research, development, and marketing groups in the organization and is responsible for delivering strategic insights to leadership in Lilly's Cardiometabolic Health (CMH) group. The ideal candidate will excel in a fast-paced, dynamic environment and possess strong communication skills and attention to detail.
Key responsibilities:- Develop expertise on the cardiovascular & gene editing market landscapes. Closely monitor relevant competitive efforts. Build a deep understanding of the needs of patients, physicians, and payers. Socialize learnings with CMH leadership & key business partners.
- Own the asset profiles, value propositions, and other key commercial materials for the ASCVD gene editing portfolio and evolve them as data read out. Ensure that these deliverables reflect customer insights and set our assets up for commercial success (beyond registration).
- Partner with market research colleagues to design and run the key market research that will shape strategy across clinical development and commercial planning.
- Partner with discovery, early-phase and late-phase colleagues to shape development plans across the ASCVD gene editing portfolio. Provide the commercial perspective on study design and evidence needs.
- Engage key regions and global affiliates to develop a global view of the market landscape and customer needs.
- Lead the commercial deliverables at each development milestone, including forecasts, risk-adjusted valuations, and investment recommendations to governance.
Basic Requirements- 5+ years in the pharmaceutical or biotechnology industry in new product planning, commercial strategy, or strategy consulting serving those functions.
Additional Skills & Preferences- Advanced degree (MBA, PhD, PharmD or MS).
- Experience in cardiovascular disease, lipid management and/or genetic medicines.
- Comfort with scientific data and the ability to translate technical insight into commercial implications.
- Experience with forecasting and risk-adjusted valuation.
- Ability to advance work streams with speed in the face of ambiguity.
- Deep scientific curiosity.
- Proven ability to effectively challenge conventional wisdom at all levels to produce innovative, patient-oriented solutions.
- Clear written and spoken communication to scientific and non-scientific audiences.
Actual compensation will depend on a candidate's education, experience, skills, and geographic location. The anticipated wage for this position is
$166,500 - $244,200
Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly's compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#WeAreLilly
